
View larger version (28K):
[in a new window]
|
Figure 1. Effects of elastin peptides on MMP expression. Human gingival fibroblasts, at confluence, were treated with 100 µg/mL kappa-elastin (kE) in serum-free medium, and urokinase-plasminogen activator (uPA), MMPs, and TIMPs expressions were analyzed by RTPCR (A). C, control (i.e., cells cultured in the absence of kE). Variations in MMP-1, MMP-3, and MMP-2 levels (B) were obtained from Western blotting (MMP-1,-3) and gelatin zymography (MMP-2); they were quantified by image analysis (Vilbert-Loumat, France) and are representative of separate experiments with 6 different fibroblast strains. Bars indicate standard deviations. Significantly different from control: *p < 0.03; **p < 0.005. S-Gal expression by human gingival fibroblasts mediates MMP-3 up-regulation (C). The presence of the S-Gal elastin receptor in gingival fibroblasts (2) was identified by Western blotting (CI) with an antibody directed against the V14 peptide, corresponding to the spliced ßGAL region; dermal fibroblast (1) plasma membranes were similarly analyzed. (CII) The influences of VGVAPG (200 µg/mL), (VGVAPG)3 (200 µg/mL), and kE (100 µg/mL) on MMP-3 expression were compared; control (100%) refers to fibroblasts cultured in the absence of peptides. (CIII) Effects of lactose (50 µmol/L), vß3 blocking antibody (AB vß3; 10 µg/mL), and U0126 (10 nmol/L, an ERK1/2 inhibitor) on kE-mediated MMP-3 up-regulation (100%). Data presented are means from experiments performed in triplicate from 3 different cell strains.
|